OncoSpherix is pleased to announce that Thomas Saylor has joined the company’s business advisory board. Mr. Saylor has served as CEO of six emerging biotech companies in the U.S., Europe and Asia, leading enterprises that cover drug development, pharmaceutical marketing, and technologies for gene therapy, drug delivery and formulation. His experience includes fundraising, strategy development, in- and out-licensing and acquisitions in Asia, Europe and the United States. Mr. Saylor has also been actively involved in public policy as a member of the Executive Committee of the British North America Committee and Vice-Chairman and a member of the board of EuropaBio, the European bioindustry association. He is also a Trustee for the Georgia Tech Research Corporation and a Senior Advisor for the Georgia Research Alliance. “We are very fortunate that Tom has joined our business advisory board and is sharing his insights with OncoSpherix ”, stated Dr. Margaret K. Offermann, OncoSpherix’s CEO. “The company is benefiting from his knowledge and perspective as we grow our team, secure resources, and develop a strategy designed to build shareholder value and achieve clinical success”.
